Patent details

Basic Information

Publication number:

EP3626723

PCT Application Number:

CN2018087247

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP188015622

PCT Publication Number:

WO2018210297

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

INTERMEDIATE OF ERIBULIN AND PREPARATION METHOD THEREFOR

French Title of Invention:

INTERMÉDIAIRE D'ÉRIBULINE ET PROCÉDÉ DE PRÉPARATION ASSOCIÉ

German Title of Invention:

ZWISCHENPRODUKT VON ERIBULIN UND HERSTELLUNGSVERFAHREN DAFÜR

SPC Number:

Dates

Filing date:

17/05/2018

Grant date:

30/06/2021

EP Publication Date:

25/03/2020

PCT Publication Date:

22/11/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/06/2021

EP B1 Publication Date:

30/06/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/05/2022

Expiration date:

17/05/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/06/2021

 

 

Name:

Selection Bioscience LLC

Address:

4th Floor Building 1 No.230 Cailun Road Shanghai Free Trade Zone, Shanghai 201203, China (CN)

Inventor

1

Name:

ZHANG, Xinning

Address:

China (CN)

2

Name:

ZHANG, Fuyao

Address:

China (CN)

3

Name:

LI, Huoming

Address:

China (CN)

Priority

Priority Number:

201710350260

Priority Date:

17/05/2017

Priority Country:

China (CN)

Classification

IPC classification:

C07F 7/18; C07D 407/06; C07D 409/06; C07D 307/28; C07D 493/22; C07D 407/14; C07D 409/14; C07D 493/04;

Publication

European Patent Bulletin

Issue number:

202126

Publication date:

30/06/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages